Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.

Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.

The Southeast Asian journal of tropical medicine and public health

Saved in:

Bibliographic Details
Main Authors:	Guan, R., Ng, H.S., Fock, K.M., Ho, K.Y., Yap, I., Kang, J.Y., Chow, W.C., Chew, C.N., Ng, C., Teo, C.J.
Other Authors:	MEDICINE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/117735
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.
by: Guan, R., et al.
Published: (2016)

Immunogenicity of Hepatitis B Vaccine in Pediatric Systemic Lupus Erythematosus Patients
by: Madaeng T.
Published: (2023)

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
by: Pornthep Chanthavanich, et al.
Published: (2019)

Hepatitis B vaccination in chronic renal failure patients undergoing haemodialysis: The immunogenicity of an increased dose of a recombinant DNA hepatitis B vaccine
by: Guan, R., et al.
Published: (2014)

Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine
by: Pushpa Ranjan Wijesinghe, et al.
Published: (2018)

The immunogenicity of low dose intradermal recombinant hepatitis B vaccination compared to standard dose
by: , PADMOMARTONO, Soemanto, et al.
Published: (1998)

Hepatitis B vaccination: Half dose recombinant DNA hepatitis B vaccine (B-Hepavac II) is as immunogenic as the full recommended dose in healthy adults
by: Guan, R., et al.
Published: (2014)

Hepatitis B vaccination: Half dose recombinant DNA hepatitis B vaccine (B-Hepavac II) is as immunogenic as the full recommended dose in healthy adults
by: Guan, R., et al.
Published: (2016)

Whole inactivated dengue virus-loaded trimethyl chitosan nanoparticle-based vaccine: immunogenic properties in ex vivo and in vivo models
by: Tuksin Jearanaiwitayakul, et al.
Published: (2022)

Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine
by: Kanokudom S.
Published: (2023)

Immunogenicity of a low dose recombinant DNA hepatitis B vaccine in healthy adults in Singapore
by: Guan, R., et al.
Published: (2014)

The immunogenicity of low dose intra dermal recombinant hepatitis b vaccination, compared to standard dose
by: Perpustakaan UGM, i-lib
Published: (1998)

Immunogenicity, reactogenicity and safety of a diphtheria-tetanus-acellular pertussis-inactivated polio and Haemophilus Influenzae type b combination vaccine in a placebo-controlled rotavirus vaccine study
by: Kong, B.P., et al.
Published: (2016)

Linguistic pride towards Singapore English amongst Chinese Singaporeans
by: Ng, Michelle Ee Xiang
Published: (2023)

Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated COVID-19 vaccine followed by an mRNA vaccine in children aged 5-11 years
by: Wanlapakorn N.
Published: (2023)

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients
by: Bruminhent J.
Published: (2023)

An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages
by: Tambyah, Paul A, et al.
Published: (2021)

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
by: Chayachinda C.
Published: (2023)

A Prospective Immunogenicity Study of a Quadrivalent Inactivated Influenza Vaccine among Persons with HIV with Different Levels of CD4 Cell Count
by: Satanon S.
Published: (2023)

Singaporean heroes in uniform : they are amongst us
by: Ong, Weichong
Published: (2014)

A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX™ in healthy children
by: Lau, Y.-L., et al.
Published: (2013)

Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates
by: A. Assateerawatt, et al.
Published: (2018)

Characterization of Influenza Vaccine Immunogenicity Using Influenza Antigen Microarrays
by: Price J.V., et al.
Published: (2020)

Intradermal hepatitis B virus immunization: Immunogenicity and reactogenicity
by: S. Sirinavin, et al.
Published: (2018)

Immunogenicity and safety of an inactivated pandemic H1N1 vaccine provided by the Thai ministry of public health as a routine public health service
by: Opart Kankawinpong, et al.
Published: (2018)

Volunteerism amongst Singaporean undergraduates : a study
by: Ang, Yi Xin
Published: (2013)

Anthroponymy across the decades amongst the Chinese Singaporeans
by: Gan, Chloe Jing Yong
Published: (2023)

Study on the comparative immunogenicity of a recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein with non pre-S containing vaccines
by: Yap, I., et al.
Published: (2014)

Study on the comparative immunogenicity of a recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein with non pre-S containing vaccines
by: Yap, I., et al.
Published: (2016)

Recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein - A preliminary study on immunogenicity
by: Yap, I., et al.
Published: (2016)

Recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein - A preliminary study on immunogenicity
by: Yap, I., et al.
Published: (2014)

Comparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: A randomized, controlled trial
by: Chaiklang K., et al.
Published: (2014)

Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine
by: Sarinya Boongird, et al.
Published: (2022)

Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine
by: Boongird S.
Published: (2023)

Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients
by: Jackrapong Bruminhent, et al.
Published: (2022)

The immunogenicity of intradermal influenza vaccination in COPD patients
by: Benjamas Chuaychoo, et al.
Published: (2018)

Loneliness amongst low-socioeconomic status elderly singaporeans and its association with perceptions of the neighbourhood environment
by: En Wee, L., et al.
Published: (2022)

Autoimmune hepatitis in Singapore: A rare syndrome affecting middle-aged women
by: Lee, Y.M., et al.
Published: (2014)

BARRIERS TO BREAST CANCER SCREENING AMONGST SINGAPOREAN WOMEN
by: THIEN ZHI YANG REUBEN
Published: (2023)

Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen
by: Wang, Y.M., et al.
Published: (2014)